CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,409,712 | -16.0% | 43,725 | +13.2% | 0.27% | -12.8% |
| Q2 2023 | $5,250,813 | +5.9% | 38,640 | -59.5% | 0.31% | -0.9% |
| Q1 2023 | $4,960,219 | +116721.0% | 95,422 | +99.2% | 0.32% | +6.4% |
| Q4 2022 | $4,246 | -99.9% | 47,906 | -1.2% | 0.30% | +4.6% |
| Q3 2022 | $3,886,000 | -11.5% | 48,471 | +5.7% | 0.28% | +1.8% |
| Q2 2022 | $4,391,000 | -36.5% | 45,853 | -1.5% | 0.28% | -22.7% |
| Q1 2022 | $6,916,000 | +10.0% | 46,558 | +5.0% | 0.36% | +18.8% |
| Q4 2021 | $6,285,000 | -10.7% | 44,335 | -17.6% | 0.30% | -13.6% |
| Q3 2021 | $7,041,000 | -1.5% | 53,820 | +3.5% | 0.35% | -1.7% |
| Q2 2021 | $7,148,000 | +7.7% | 52,011 | +2.3% | 0.36% | +3.2% |
| Q1 2021 | $6,639,000 | +16.5% | 50,840 | -0.1% | 0.35% | +22.6% |
| Q4 2020 | $5,701,000 | -17.1% | 50,904 | -41.7% | 0.28% | -18.9% |
| Q3 2020 | $6,873,000 | +7.4% | 87,365 | -1.7% | 0.35% | +2.3% |
| Q2 2020 | $6,400,000 | – | 88,903 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 41,984 | $4,234,086 | 3.80% |
| Ranger Investment Management | 334,874 | $33,772,043 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 114,000 | $11,496,900 | 2.24% |
| EARNEST PARTNERS LLC | 2,265,092 | $228,434,528 | 1.32% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 144,376 | $14,560,320 | 1.01% |
| EPIQ PARTNERS, LLC | 10,463 | $1,055,194 | 0.80% |
| Hood River Capital Management LLC | 236,127 | $23,813,408 | 0.76% |
| Heritage Wealth Partners, LLC | 3,375 | $340,369 | 0.73% |
| Champlain Investment Partners, LLC | 943,260 | $95,127,771 | 0.62% |
| WESTWOOD HOLDINGS GROUP INC | 559,157 | $56,391 | 0.53% |